Table 2.
Stimulated cycle results and laboratory characteristics for the fresh cycle
DFET (n = 105) | cSFET (n = 60) | eSFET (n = 41) | |
---|---|---|---|
Days of stimulation | |||
Mean ± SD | 10.7 ± 1.6 | 9 ± 2.2 | 10.5 ± 1.7 |
Total dose of FSH (UI) | |||
Mean ± SD | 1,938 ± 704 | 1,621 ± 607 | 1,864 ± 564 |
E2 day hCG (pg/mL) | |||
Mean ± SD | 2,390 ± 1,344 | 2,171 ± 1,564 | 2,355 ± 1,167 |
Protocol, n (%) | |||
Antagonist | 22 (29.4) | 14 (29.2) | 6 (28.6) |
Long analogue | 53 (71.6) | 34 (70.8) | 15 (71.4) |
Oocytes obtained | |||
Mean | 12.5 ± 4.5 | 10.4 ± 4.2 | 11.1 ± 4.5 |
Range | (4–16) | (3–16) | (3–18) |
Oocytes MII | |||
Mean | 11.2 ± 4.3 | 8.9 ± 4.0 | 9.0 ± 3.9 |
Range | (4–16) | (1–16) | (2–18) |
Oocytes MII rate (%) | 89.6 | 85.6 | 81.8 |
Fertilised oocytes | |||
Mean | 8.6 ± 3.5 | 6.2 ± 3.3 | 6.5 ± 3.3 |
Range | (2–12) | (2–10) | (2–14) |
Fertilisation rate (%) | 76.7 | 70.2 | 72.2 |
Good-quality embryos vitrified (A/B) | |||
Mean | 2.3 ± 2.3 | 1.0 ± 0 | 2.4 ± 1.9 |
Range | (2–4) | (1) | (2–3) |
Day of transfer, n (%) | |||
D + 2 | 31 (29.5) | 18 (30.0) | 12 (29.3) |
D + 3 | 74 (70.5) | 42 (70.0) | 29 (70.7) |
Mean ± SD (min–max)
NS